{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:12:50Z","timestamp":1778850770538,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020483","name":"Insmed Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.resinv.2026.101414","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:17:27Z","timestamp":1775135847000},"page":"101414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of timing of nontuberculous mycobacterial pulmonary disease antibiotic initiation on hospitalizations in Japan"],"prefix":"10.1016","volume":"64","author":[{"given":"Catherine","family":"Waweru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8239-9275","authenticated-orcid":false,"given":"Kozo","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5656-8469","authenticated-orcid":false,"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1874-066X","authenticated-orcid":false,"given":"Emily","family":"Welch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.resinv.2026.101414_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.resinv.2026.101414_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00337-2024","article-title":"Laboratory-based surveillance of nontuberculous mycobacterial pulmonary disease in Japan","volume":"11","author":"Hamaguchi","year":"2025","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.resinv.2026.101414_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1513\/AnnalsATS.201806-366OC","article-title":"Epidemiology of adults and children treated for nontuberculous mycobacterial pulmonary disease in Japan","volume":"16","author":"Izumi","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.resinv.2026.101414_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00911-2023","article-title":"Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan","volume":"10","author":"Wang","year":"2024","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.resinv.2026.101414_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00424-2022","article-title":"Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan","volume":"9","author":"Morimoto","year":"2023","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.resinv.2026.101414_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1513\/AnnalsATS.201607-573OC","article-title":"A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013","volume":"14","author":"Morimoto","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.resinv.2026.101414_bib7","first-page":"29","article-title":"Guidelines for chemotherapy of pulmonary nontuberculous mycobacterial disease--2012 revised version. Kekkaku","volume":"88","year":"2013"},{"issue":"4","key":"10.1016\/j.resinv.2026.101414_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.resinv.2026.101414_bib9","article-title":"Statement for chemotherapy for adult pulmonary nontuberculous mycobacterial disease\u20132023 revised version","volume":"98","year":"2024","journal-title":"Kekkaku"},{"key":"10.1016\/j.resinv.2026.101414_bib10","unstructured":"JMDC Claims Database https:\/\/www.jmdc.co.jp\/en\/jmdc-claims-database\/. [Accessed 23 June 2025]."},{"issue":"4","key":"10.1016\/j.resinv.2026.101414_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/23120541.00963-2023","article-title":"Reductions in hospitalisations and emergency department visits with early antibiotic initiation in nontuberculous mycobacterial lung disease","volume":"10","author":"Winthrop","year":"2024","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.resinv.2026.101414_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chest.2024.03.024","article-title":"Rates and risk factors of progression in patients with nontuberculous mycobacterial pulmonary disease: secondary analysis of a prospective cohort study","volume":"166","author":"Hyung","year":"2024","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.resinv.2026.101414_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18967","article-title":"Longitudinal changes in radiographic features of pulmonary","volume":"9","author":"Watanabe","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.resinv.2026.101414_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01240-2019","article-title":"Clinical efficacy and safety of fluoroquinolone containing regimens in patients with Mycobacterium avium complex pulmonary disease","volume":"55","author":"Khadawardi","year":"2020","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.resinv.2026.101414_bib15","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1513\/AnnalsATS.201604-246OC","article-title":"Macrolide-resistant Mycobacterium avium complex lung disease: analysis of 102 consecutive cases","volume":"13","author":"Morimoto","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.resinv.2026.101414_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11748-015-0594-z","article-title":"Current status of nontuberculous mycobacterial surgery in Japan: analysis of data from the annual survey by the Japanese Association for Thoracic Surgery","volume":"64","author":"Shiraishi","year":"2016","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.resinv.2026.101414_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/pds.2049","article-title":"The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy","volume":"20","author":"Winthrop","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.resinv.2026.101414_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.31662\/jmaj.2023-0078","article-title":"Literature review of studies using the National Database of the Health Insurance Claims of Japan (NDB): limitations and strategies in using the NDB for research","volume":"7","author":"Suto","year":"2024","journal-title":"JMA J"},{"issue":"6","key":"10.1016\/j.resinv.2026.101414_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.resinv.2017.08.007","article-title":"Health checkup system and pulmonary nontuberculous mycobacterial disease","volume":"55","author":"Fukuoka","year":"2017","journal-title":"Respir Investig"},{"issue":"10","key":"10.1016\/j.resinv.2026.101414_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01105-18","article-title":"Nontuberculous mycobacterial lung diseases caused by mixed infection with Mycobacterium avium complex and Mycobacterium abscessus complex","volume":"62","author":"Shin","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:59:33Z","timestamp":1778849973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2212534526000481"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101414","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of timing of nontuberculous mycobacterial pulmonary disease antibiotic initiation on hospitalizations in Japan","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}],"article-number":"101414"}}